Blogs

  1. Navigating The Cell And Gene Regulatory Landscape 10/3/2024

    Navigating the complex regulatory landscape is essential for cell and gene therapy success. Explore key considerations, challenges, and best practices for companies operating in this space.

  2. Key Takeaways And Market Insights From The Inaugural ThinkLive Summit 8/30/2024

    The inaugural ThinkLive Cell and Gene Therapy Summit explored the industry’s dynamic landscape, highlighting collaboration, communication, and market access challenges.

  3. How Patient-Centric Approaches Are Shaping The Future Of CGT 8/6/2024

    Emily Whitehead’s CAR-T cell therapy journey highlights the power of patient engagement in cell and gene therapies. Discover how her story and advocacy drive a patient-centric approach in innovative treatments.

  4. Pre-Launch Checklist - A Roadmap To Success 6/21/2024

    The path from groundbreaking therapy to readily available treatment requires a strategic approach. Delve into ten critical questions that can help you chart a successful course for your CGT therapy.

  5. Navigating CGT Commercialization: Key Areas For Success 5/13/2024

    The cutting-edge realm of cell and gene therapy holds immense promise for revolutionizing healthcare, and its successful commercialization hinges on several key factors.

  6. A Comparative Guide To CGTs: Modalities, Landscape, And Logistics 2/29/2024

    Cell and gene therapies (CGTs) have the potential to revolutionize medicine. However, achieving therapeutic success requires advanced logistical consideration to ensure product safety and efficacy

  7. Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And Solutions 12/8/2023

    Explore critical logistical requirements in autologous cell therapies logistics and learn how to overcome challenges and achieve successful and timely autologous cell therapy trials.

  8. Crafting An Effective Commercialization Strategy For CGTs 10/25/2023

    Patient access and manufacturing efficiency persist as barriers to widespread adoption of CGTs. An effective commercialization strategy is crucial to expand access to these life-changing therapies.